Decreased mutagenic activity of the prodrug NFOH-121 related to nitrofurazona;Diminuição da atividade mutagênica do pró-fármaco NFOH-121 em relação ao nitrofural (nitrofurazona)

Revista de Ciencias Farmaceuticas

Volumn 22, Issue 2, 2001, Pages 319-333

  Güido, Rafael Victorio Carbalho ^a   Ferreira, Elizabeth Igne ^a   Nassute, José Carlos ^a   Varanda, Eliana Aparecida ^a   Chung, Man Chin ^a  

^a Fac Ci Farmaceut   (Brazil)

Author keywords

Antichagasic activity; Chagas' disease; Latenciation; Mutagenicic; NFOH 121; Nitrofurazone; Prodrug

Indexed keywords

BENZNIDAZOLE; LAPDESF; NFOH 121; NIFURTIMOX; NITROFURAL; PRODRUG; UNCLASSIFIED DRUG;

AMES TEST; ANTIPROTOZOAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; MOLECULAR GENETICS; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM; TOXICITY;

EID: 0035758007     PISSN: 01013793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Study on the mutagecity of Nifurtimox and eight derivates with L-arabinose resistence test of Salmonella typhimurium
2. Parasitic disease
3. Ação da nitrofurazona (5-nitro-2-furaldeidosemicarbazona) sobre as formas intracelulares do Trypanosoma cruzi na doença de Chagas experimental
4. Nirofuran induced mutagenesis and errorprone repair in Escherichia coli
5. Novel chemical approaches in prodrug design
6. O processo de latenciação no planejamento de fármacos
7. Nitrofurazone therapy in "middle bums": A review
8. Mechanistic interpretation of the genotoxicity of nitrofurans (antibacteriam agents) using quantitative structure -activity relationship and comparative molecular field analysis
9. Doença de Chagas: Epidemiologia e prevenção
10. Epidemiologia
11. Doença de Chagas no Brasil - Situação atual e perspectivas
12. The in vitro bacteriostatic action of some simple furan derivatives
13. Design and application of prodrugs
14. Studies on the effect of acid ascorbic and selenium on the genotoxicity of nitrofurans: Nitrofurazone and furazolidone
15. 2 infectadas com formas tripomastigotas de Trypanosoma cruzi
16. "Subversive" substrates for the enzyme trypanothione disulfide reductase: Alternative approach to chemotherapy of Chagas disease
17. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds
18. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: A pharmaceutical industry perspective
19. Revised methods for Salmonella mutagenicity test
20. Fatal imbalance. The crisis in research and development for drugs for neglected disease
21. Chagas' disease: Epidemiology and prospects for interruption of transmisi6n in the Americas
22. Epidemiologia e controle da transmissão vetorial da doença de Chagas
23. Drugs used in the chemotherapy of protozoal infections
24. Atividade antimicrobiana dopro-fármaco hidroximetilnitrofurazona
25. Monitoring São Paulo state river in Brasil for mutagenic activity using the Ames test
26. Mutagenic activity detected by the Ames test in river water under the influence of petrochemical industries
27. Mutagenicities of nitrofuran derivatives on a bacterial tester strain with R factor plasmid
28. Nitrofurazone as a mutagen in Escherichia coli